Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Intervention of Preclinical Atherosclerosis With Tongmai Jiangzhuo Granules
ChiCTR-IIR-16008601Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Start
- Jul 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tongmai Jiangzhuo granules in atherosclerosis (2 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoint: Carotid intima-media thickness (IMT). Planned start Jul 2015; status: not yet recruiting.
02
Drugs
Tongmai Jiangzhuo granules
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on ChiCTR-IIR-16008601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008601.